Shuttle Pharmaceuticals Holdings (SHPH) Receivables - Other (2023 - 2024)

Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Receivables - Other of $4.0 in Q3 2024, down 99.94% quarter-over-quarter from $7226.0 in Q2 2024, and down 99.97% on a YoY basis from $12435.0 in Q4 2023.

Shuttle Pharmaceuticals Holdings (SHPH) Receivables - Other (2023 - 2024) Analysis & Trends

Shuttle Pharmaceuticals Holdings' Receivables - Other history runs 2 years deep, the most recent figure standing at $4.0 for Q3 2024.

  • In Q3 2024, Receivables - Other fell 99.97% year-over-year to $4.0; the TTM figure through Sep 2024 stood at $4.0 (down 99.97% YoY), while the FY2023 annual figure was $14901.0, changed N/A from the prior year.
  • Receivables - Other was $4.0 for Q3 2024 at Shuttle Pharmaceuticals Holdings, down from $7226.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $14901.0 in Q4 2023 to a low of $4.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Shuttle Pharmaceuticals Holdings 2.32 Mn 1.26 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2024 4.00
Sep 30, 2024 4.00
Jun 30, 2024 7,226.00
Jun 30, 2024 7,226.00
Mar 31, 2024 11,964.00
Mar 31, 2024 11,964.00
Dec 31, 2023 14,901.00
Dec 31, 2023 14,901.00
Sep 30, 2023 12,435.00
Sep 30, 2023 12,435.00
Jun 30, 2023 6,950.00
Jun 30, 2023 6,950.00
Mar 31, 2023 7,023.00
Mar 31, 2023 7,023.00